Patents by Inventor Mark S. Pasternack

Mark S. Pasternack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5017489
    Abstract: Antibodies, nucleic acid sequences, and methods for inhibition of lysis for a novel serine esterase produced by both murine and human cytotoxic T lymphocytes. The serine esterase has an apparent molecular weight of approximately 28,000-31,000, as determined by SDS gel electrophoresis under reducing conditions, and trypsin-like activity. Inhibition of the esterase correlates with inhibition of the cells' cytolytic activity. Specific inhibition of the serine esterase is useful as a method for immunosuppression as well as for the inhibition of cytolytic activity of T lymphocytes, both in vivo and in vitro. The genes encoding the murine and human serine esterase are homologous.
    Type: Grant
    Filed: August 22, 1988
    Date of Patent: May 21, 1991
    Assignee: Massachusetts Institute of Technology
    Inventors: Mark S. Pasternack, Herman S. Eisen
  • Patent number: 4783410
    Abstract: A novel serine esterase produced by cytotoxic T lymphocytes is insolated and characterized. The protein appears to be membrane bound and has a reduced apparent molecular weight of about 28,000 daltons. Inhibition of the esterase correlates with inhibition of the cells' cytolytic activity. The serine esterase is useful in making antibody and as a target for the inhibition of cytolytic activity by T-lymphocytes, both in vivo and in vitro.
    Type: Grant
    Filed: June 28, 1985
    Date of Patent: November 8, 1988
    Assignee: Massachusetts Institute of Technology
    Inventors: Mark S. Pasternack, Herman N. Eisen